Literature DB >> 365403

The significance of pure diffuse mesangial proliferation in idiopathic nephrotic syndrome.

R Waldherr, M C Gubler, M Levy, M Broyer, R Habib.   

Abstract

The prognostic significance of the finding of diffuse mesangial proliferation (DMP) in patients presenting with idiopathic nephrotic syndrome (INS) has not been well established. The clinical course, therapeutic response and final outcome of 38 patients in whom renal biopsy showed DMP are reported. They have been subdivided into 2 groups according to the absence (18 patients: group I) or presence (20 patients: group II) of superimposed lesions of focal and segmental sclerosis and/or hyalinosis (FSS/H). Clinical presentation was similar in both groups although patients in group I were less severely affected. Non of the patients of group II responded to corticosteroids, whereas in group I 2/16 responded and 2 infants remitted without treatment. At the latest assessment, 5/18 patients in group I and 10/20 in group II had progressed to terminal renal failure or had impaired renal function. Five patients in group I and 3 in group II were in clinical remission. Eight of 11 repeat biopsies performed in patients of group I showed the development of FSS/H. Thus patients with DMP seem prone to develop lesions of FSS/H. Their course if often worse than that of minimal change with FSS/H since 7 of the 10 patients who developed renal failure did so within 3 years of onset. The finding of DMP in a patient with idiopathic nephrotic syndrome is usually but not invariably an ominous feature.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 365403

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  16 in total

1.  Long-term outcome of idiopathic steroid-resistant nephrotic syndrome in children: response to comments.

Authors:  Aya Inaba; Yuko Hamasaki; Kenji Ishikura; Tetsuji Kaneko
Journal:  Pediatr Nephrol       Date:  2015-12-01       Impact factor: 3.714

2.  Focal glomerulosclerosis in children: an Argentinian experience.

Authors:  A Tufro-McReddie; E Alvarez; E Arrizurieta; H Repetto
Journal:  Pediatr Nephrol       Date:  1992-03       Impact factor: 3.714

3.  NPHS2 mutations in sporadic steroid-resistant nephrotic syndrome in Japanese children.

Authors:  Kyoko Maruyama; Kazumoto Iijima; Masahiro Ikeda; Akiko Kitamura; Hiroyasu Tsukaguchi; Kunihiko Yoshiya; Sakurako Hoshii; Naohiro Wada; Osamu Uemura; Kenichi Satomura; Masataka Honda; Norishige Yoshikawa
Journal:  Pediatr Nephrol       Date:  2003-04-05       Impact factor: 3.714

4.  Adult-onset minimal change disease: the significance of histological chronic changes for clinical presentation and outcome.

Authors:  Gabriel Stefan; Ruxandra Busuioc; Simona Stancu; Madalina Hoinoiu; Adrian Zugravu; Nicoleta Petre; Gabriel Mircescu
Journal:  Clin Exp Nephrol       Date:  2020-10-22       Impact factor: 2.801

5.  IgM associated primary diffuse mesangial proliferative glomerulonephritis.

Authors:  W Lawler; G Williams; P Tarpey; N P Mallick
Journal:  J Clin Pathol       Date:  1980-11       Impact factor: 3.411

6.  Nephrotic syndrome with slight proliferative changes: response to prednisone.

Authors:  K T Woo; E J Lee; C H Lim
Journal:  Br Med J       Date:  1980-09-20

7.  Minimal change nephrotic syndrome. Histopathology and steroid-responsiveness.

Authors:  J Bernstein; C M Edelmann
Journal:  Arch Dis Child       Date:  1982-11       Impact factor: 3.791

8.  The prognostic value of glomerular immaturity in the nephrotic syndrome in children.

Authors:  Danuta Ostalska-Nowicka; Jacek Zachwieja; Janusz Maciejewski; Aldona Woźniak; Wiesława Salwa-Urawska
Journal:  Pediatr Nephrol       Date:  2004-04-08       Impact factor: 3.714

9.  Late development of purpura in a patient with glomerulonephritis.

Authors:  A V Cybulsky; S Jothy; J F Seely
Journal:  Can Med Assoc J       Date:  1984-01-15       Impact factor: 8.262

10.  Mesangial alterations in steroid-responsive minimal change nephrotic syndrome.

Authors:  J Fydryk; R Waldherr; G Mall; K Schärer
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1982
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.